53 results on '"Jett, James R."'
Search Results
2. Screening for lung cancer: current status and future directions *: Thomas A. Neff lecture
3. Guidelines on treatment of stage IIIB non-small cell lung cancer *
4. New agents in the treatment of small cell lung cancer
5. Tumors of the middle and posterior mediastinum
6. Tumors of the anterior mediastinum
7. A prospective study of pulmonary function in patients receiving mitomycin
8. Body plethysmography in the evaluation of intrathoracic airway abnormalities
9. Fatal Radiation Pneumonitis in Patients With Subclinical Interstitial Lung Disease.
10. Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
11. Extent of Resection and Lymph Node Assessment for Clinical Stage T1aN0M0 Typical Carcinoid Tumors.
12. Typical and Atypical Pulmonary Carcinoids(*)
13. Scientific Advances in Thoracic Oncology 2016.
14. Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer: NCCTG N0028 (Alliance).
15. What's new in staging of lung cancer?
16. Malignant pleural mesothelioma: a proposed new staging system
17. Trimodality Therapy for Superior Sulcus Non-Small Cell Lung Cancer: Southwest Oncology Group-Intergroup Trial S0220.
18. Audit of the autoantibody test, EarlyCDT®-Lung, in 1600 patients: An evaluation of its performance in routine clinical practice.
19. Development of a multivariate model to predict the likelihood of carcinoma in patients with indeterminate peripheral lung nodules after a nondiagnostic bronchoscopic evaluation.
20. Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma.
21. Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: an NCCTG-97-24-51 based study.
22. Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007.
23. Lung cancer screening in 2008: A review and update.
24. Response to Letter to the Editor.
25. Impact of Pretreatment Factors on Adverse Events: A Pooled Analysis of North Central Cancer Treatment Group Advanced Stage Non-small Cell Lung Cancer Trials.
26. Profiling Tumor-Associated Antibodies for Early Detection of Non-small Cell Lung Cancer.
27. Topotecan and paclitaxel in previously treated patients with relapsed small cell lung cancer: phase II trial of the North Central Cancer Treatment Group.
28. Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002.
29. Screening for lung cancer with low-dose CT scans
30. State of the Journal: 2010.
31. State of the Journal.
32. State of the Journal.
33. The role of Positron Emission Tomography (PET) in the evaluation of Paraneoplastic Neurologic Syndrome (PNS).
34. Pulmonary toxicity of therapy.
35. JTO: An Excellent First Year!
36. The New Official Journal of the IASLC.
37. Computed tomographic screening for lung cancer: home run or foul ball?
38. A phase II NCCTG “Window of Opportunity Front-line” study of the mTOR Inhibitor, CCI-779 (Temsirolimus) given as a single agent in patients with advanced NSCLC.
39. E33. Pet scanning for evaluation of solitary pulmonary nodule and staging of NSCLC
40. Superior sulcus tumors and Pancoast’s syndrome
41. How to optimize staging in early non-small cell lung cancer
42. Effectiveness of smoking cessation self-help materials in a lung cancer screening population
43. Imatinib Mesylate-Induced Interstitial Pneumonitis.
44. Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)
45. Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer
46. Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: Contemporary experience from a single institution
47. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer
48. Glomus Tumor of the Trachea: Value of Multidetector Computed Tomographic Virtual Bronchoscopy.
49. Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer1 <FN ID="FN1"><NO>1</NO>This study was conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic. Additional participating institutions included Cedar Rapids Oncology Project CCOP, Cedar Rapids, IA; Meritcare Hospital CCOP, Fargo, ND; Sioux Community Cancer Consortium, Sioux Falls, SD; Geisinger Clinical Oncology Program, Danville, PA (Suresh Nair, M.D.); Rapid City Regional Oncology Group, Rapid City, SD (Larry P. Ebbert, M.D.), Saskatchewan Cancer Centre, Saskatoon, Saskatchewan, Canada; Allan Blair Cancer Centre, Regina, Saskatchewan, Canada (Maria Tria Tirona, M.D.); Scottsdale CCOP, Scottsdale, AZ (Tom R. Fitch, M.D.); Carle Cancer Center CCOP, Urbana, IL (Kendrith M. Rowland, M.D.); Medcenter One Health Systems, Bismarck, ND (Ferdinand Addo, M.D.); Altru Health Systems, Grand Forks, ND (Daniel J. Walsh, M.D.); Siouxland Hematology-Oncology Associates, Sioux City, IA (John C. Michalak, M.D.); and CentreCare Clinic, St. Cloud, MN (Harold E. Windschitl, M.D.).</FN>
50. A quality-adjusted reanalysis of a Phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer1 <FN ID="FN1"><NO>1</NO>This study was conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic.</FN>
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.